{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:31:33Z","timestamp":1793107893163,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.clim.2021.108756","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T12:12:30Z","timestamp":1620907950000},"page":"108756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma"],"prefix":"10.1016","volume":"228","author":[{"given":"Patrick","family":"Coit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaila L.","family":"Schollaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Mirizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn S.","family":"Torok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr H.","family":"Sawalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clim.2021.108756_bb0005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.pcl.2012.03.011","article-title":"Pediatric scleroderma: systemic or localized forms","volume":"59","author":"Torok","year":"2012","journal-title":"Pediatr. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.clim.2021.108756_bb0010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.pcl.2018.04.002","article-title":"Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis","volume":"65","author":"Li","year":"2018","journal-title":"Pediatr. Clin. N. Am."},{"issue":"12","key":"10.1016\/j.clim.2021.108756_bb0015","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1002\/art.22207","article-title":"Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database","volume":"54","author":"Martini","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.clim.2021.108756_bb0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/rheumatology\/ken388","article-title":"Factors affecting survival in juvenile systemic sclerosis","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.clim.2021.108756_bb0025","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/acr.23547","article-title":"Clinical characteristics and factors associated with disability and impaired quality of life in children with juvenile systemic sclerosis: results from the childhood arthritis and rheumatology research alliance legacy registry","volume":"70","author":"Stevens","year":"2018","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2021.108756_bb0030","article-title":"Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in expanded international cohort. www.juvenile-scleroderma.com","author":"Foeldvari","year":"2021","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.clim.2021.108756_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2017.05.004","article-title":"Unfolding the pathogenesis of scleroderma through genomics and epigenomics","volume":"83","author":"Tsou","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2021.108756_bb0040","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3389\/fimmu.2019.02305","article-title":"The pathogenic role of dysregulated epigenetic modifications in autoimmune diseases","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2021.108756_bb0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12929-015-0142-2","article-title":"DNA methylation similarities in genes of black south Africans with systemic lupus erythematosus and systemic sclerosis","volume":"22","author":"Matatiele","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.clim.2021.108756_bb0050","doi-asserted-by":"crossref","first-page":"7342472","DOI":"10.1155\/2018\/7342472","article-title":"Integration of genome-wide DNA methylation and transcription uncovered aberrant methylation-regulated genes and pathways in the peripheral blood mononuclear cells of systemic sclerosis","volume":"2018","author":"Zhu","year":"2018","journal-title":"Int. J. Rheumatol."},{"key":"10.1016\/j.clim.2021.108756_bb0055","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3389\/fimmu.2019.01352","article-title":"Immunopathogenesis of juvenile systemic sclerosis","volume":"10","author":"Stevens","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2021.108756_bb0060","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jid.2018.09.025","article-title":"Identifying the signature immune phenotypes present in pediatric localized scleroderma","volume":"139","author":"Mirizio","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.clim.2021.108756_bb0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2013.07.005","article-title":"T lymphocyte abnormalities in juvenile systemic sclerosis patients","volume":"149","author":"Reiff","year":"2013","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2021.108756_bb0070","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jid.2017.12.003","article-title":"Genome-wide DNA methylation analysis in systemic sclerosis reveals hypomethylation of IFN-associated genes in CD4(+) and CD8(+) T cells","volume":"138","author":"Ding","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.clim.2021.108756_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bjd.12913","article-title":"DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis","volume":"171","author":"Wang","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2021.108756_bb0080","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3389\/fimmu.2019.00908","article-title":"Immunopathogenesis of pediatric localized scleroderma","volume":"10","author":"Torok","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2021.108756_bb0085","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.23451","article-title":"Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma","volume":"58","author":"Duan","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.clim.2021.108756_bb0090","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/annrheumdis-2014-205303","article-title":"Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies","volume":"74","author":"Altorok","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.clim.2021.108756_bb0095","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/annrheumdis-2018-213022","article-title":"Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts","volume":"77","author":"He","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.clim.2021.108756_bb0100","article-title":"Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes","volume":"45","author":"Zhou","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.clim.2021.108756_bb0105","article-title":"DNAmArray: streamlined workflow for the quality control, normalization, and analysis of Illumina methylation array data","author":"Sinke","year":"2019","journal-title":"Zenodoa"},{"issue":"10","key":"10.1016\/j.clim.2021.108756_bb0110","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","article-title":"Minfi: a flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays","volume":"30","author":"Aryee","year":"2014","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.clim.2021.108756_bb0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2217\/epi.12.21","article-title":"Complete pipeline for Infinium((R)) human methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation","volume":"4","author":"Touleimat","year":"2012","journal-title":"Epigenomics"},{"key":"10.1016\/j.clim.2021.108756_bb0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13148-018-0504-1","article-title":"Identifying mislabeled and contaminated DNA methylation microarray data: an extended quality control toolset with examples from GEO","volume":"10","author":"Heiss","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.clim.2021.108756_bb0125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2105-13-86","article-title":"DNA methylation arrays as surrogate measures of cell mixture distribution","volume":"13","author":"Houseman","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.clim.2021.108756_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13148-015-0129-6","article-title":"Nucleated red blood cells impact DNA methylation and expression analyses of cord blood hematopoietic cells","volume":"7","author":"de Goede","year":"2015","journal-title":"Clin. Epigenetics"},{"issue":"7","key":"10.1016\/j.clim.2021.108756_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041361","article-title":"Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility","volume":"7","author":"Reinius","year":"2012","journal-title":"PLoS One"},{"issue":"Web Server issue","key":"10.1016\/j.clim.2021.108756_bb0140","doi-asserted-by":"crossref","first-page":"W305","DOI":"10.1093\/nar\/gkp427","article-title":"ToppGene Suite for gene list enrichment analysis and candidate gene prioritization","volume":"37","author":"Chen","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.clim.2021.108756_bb0145","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3899\/jrheum.081284","article-title":"The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures","volume":"36","author":"Arkachaisri","year":"2009","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2021.108756_bb0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaad.2013.02.007","article-title":"The localized scleroderma cutaneous assessment tool: responsiveness to change in a pediatric clinical population","volume":"69","author":"Kelsey","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.clim.2021.108756_bb0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","article-title":"Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study","volume":"49","author":"Arkachaisri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.clim.2021.108756_bb0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13148-019-0652-y","article-title":"Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets","volume":"11","author":"Ramos","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"10","key":"10.1016\/j.clim.2021.108756_bb0165","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/1756-185X.13175","article-title":"IRF7 gene expression profile and methylation of its promoter region in patients with systemic sclerosis","volume":"20","author":"Rezaei","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.clim.2021.108756_bb0170","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fgene.2019.00223","article-title":"Genome-wide DNA methylation profiles reveal common epigenetic patterns of interferon-related genes in multiple autoimmune diseases","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Genet."},{"issue":"3","key":"10.1016\/j.clim.2021.108756_bb0175","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.clim.2009.05.011","article-title":"T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus","volume":"132","author":"Zhou","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108756_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fphar.2019.00125","article-title":"GPCR signaling regulation: the role of GRKs and Arrestins","volume":"10","author":"Gurevich","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.clim.2021.108756_bb0185","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/gene.2015.37","article-title":"Multifaceted role of beta-arrestins in inflammation and disease","volume":"16","author":"Sharma","year":"2015","journal-title":"Genes Immun."},{"key":"10.1016\/j.clim.2021.108756_bb0190","doi-asserted-by":"crossref","first-page":"155258","DOI":"10.1016\/j.cyto.2020.155258","article-title":"Interleukin-15 in autoimmunity","volume":"136","author":"Allard-Chamard","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.clim.2021.108756_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.clim.2021.108756_bb0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-kappaB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2021.108756_bb0205","first-page":"8(6)","article-title":"Regulation of TEAD transcription factors in cancer biology","author":"Huh","year":"2019","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.clim.2021.108756_bb0210","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/cdd.2008.60","article-title":"Itch: a HECT-type E3 ligase regulating immunity, skin and cancer","volume":"15","author":"Melino","year":"2008","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.clim.2021.108756_bb0215","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3892\/br.2016.785","article-title":"Critical role of calpain in inflammation","volume":"5","author":"Ji","year":"2016","journal-title":"Biomed. Rep."},{"issue":"5","key":"10.1016\/j.clim.2021.108756_bb0220","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1074\/jbc.M808992200","article-title":"Nuclear factor Y is required for basal activation and chromatin accessibility of fibroblast growth factor receptor 2 promoter in osteoblast-like cells","volume":"284","author":"Sun","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.clim.2021.108756_bb0225","first-page":"339","article-title":"Nuclear transcription factor Y and its roles in cellular processes related to human disease","volume":"3","author":"Ly","year":"2013","journal-title":"Am. J. Cancer Res."},{"issue":"5","key":"10.1016\/j.clim.2021.108756_bb0230","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/nar\/gkm1046","article-title":"A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response","volume":"36","author":"Benatti","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.clim.2021.108756_bb0235","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.gendis.2014.09.005","article-title":"Fibroblast growth factor (FGF) signaling in development and skeletal diseases","volume":"1","author":"Teven","year":"2014","journal-title":"Genes Dis."},{"issue":"5","key":"10.1016\/j.clim.2021.108756_bb0240","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.2353\/ajpath.2007.061111","article-title":"Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells","volume":"170","author":"Zhu","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.clim.2021.108756_bb0245","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","article-title":"Oligoclonal T cell expansion in the skin of patients with systemic sclerosis","volume":"168","author":"Sakkas","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108756_bb0250","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2249.2006.03041.x","article-title":"Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin","volume":"144","author":"De Palma","year":"2006","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2021.108756_bb0255","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2021.108756_bb0260","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4049\/jimmunol.134.5.2824","article-title":"Peptide growth factors PDGF, EGF, and FGF regulate interferon-gamma production","volume":"134","author":"Johnson","year":"1985","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2021.108756_bb0265","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.4049\/jimmunol.155.8.3904","article-title":"Costimulation of human CD4+ T cells by fibroblast growth factor-1 (acidic fibroblast growth factor)","volume":"155","author":"Zhao","year":"1995","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2021.108756_bb0270","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.4049\/jimmunol.162.10.5853","article-title":"Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells","volume":"162","author":"Byrd","year":"1999","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2021.108756_bb0275","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0190-9622(96)90603-9","article-title":"Serum concentrations of basic fibroblast growth factor in collagen diseases","volume":"35","author":"Kadono","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.clim.2021.108756_bb0280","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D36S6582VR","article-title":"Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis","volume":"12","author":"Lawrence","year":"2006","journal-title":"Dermatol. Online J."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:03:22Z","timestamp":1761494602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":56,"alternative-id":["S1521661621000930"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108756","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108756"}}